At iBET, I manage client-facing R&D bioprocessing projects for biologics, including antibodies and viral vectors such as lentiviral vectors, adenovirus, and AAVs. I translate client requirements into experimental plans, milestones, and reporting outputs across upstream processing, downstream purification, and analytical characterization.
Previously, I developed point-of-care diagnostic devices at Biosurfit, leading platelet-count and saliva-based recreational drug detection assays. During my PhD with Swansea University and Unilever SEAC, I designed and validated a small-scale bioreactor for a dynamic 3D in vitro alveolar model, mentored students, and authored or co-authored three peer-reviewed papers.
